150 related articles for article (PubMed ID: 9850925)
1. Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference.
Schubert P; Ogata T; Miyazaki H; Marchini C; Ferroni S; Rudolphi K
J Neural Transm Suppl; 1998; 54():167-74. PubMed ID: 9850925
[TBL] [Abstract][Full Text] [Related]
2. Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target?
Schubert P; Ogata T; Marchini C; Ferroni S
Mech Ageing Dev; 2001 Dec; 123(1):47-57. PubMed ID: 11640951
[TBL] [Abstract][Full Text] [Related]
3. Interfering with the pathologic activation of microglial cells and astrocytes in dementia.
Schubert P; Rudolphi K
Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S21-8. PubMed ID: 9769026
[TBL] [Abstract][Full Text] [Related]
4. Protective mechanisms of adenosine in neurons and glial cells.
Schubert P; Ogata T; Marchini C; Ferroni S; Rudolphi K
Ann N Y Acad Sci; 1997 Oct; 825():1-10. PubMed ID: 9369970
[TBL] [Abstract][Full Text] [Related]
5. Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline.
Schubert P; Ogata T; Rudolphi K; Marchini C; McRae A; Ferroni S
Ann N Y Acad Sci; 1997 Sep; 826():337-47. PubMed ID: 9329704
[TBL] [Abstract][Full Text] [Related]
6. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling.
Schubert P; Morino T; Miyazaki H; Ogata T; Nakamura Y; Marchini C; Ferroni S
Ann N Y Acad Sci; 2000 Apr; 903():24-33. PubMed ID: 10818485
[TBL] [Abstract][Full Text] [Related]
7. Modulation of glial cell signaling by adenosine and pharmacological reinforcement. A neuroprotective strategy?
Schubert P; Ogata T; Ferroni S; McRae A; Nakamura Y; Rudolphi K
Mol Chem Neuropathol; 1996; 28(1-3):185-90. PubMed ID: 8871958
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying cyclic AMP inhibition of macrophage dependent TNF-alpha production and neurotoxicity in response to amyloidogenic C-terminal fragment of Alzheimer's amyloid precursor protein.
Chong YH; Shin SA; Lee HJ; Kang JH; Suh YH
J Neuroimmunol; 2002 Dec; 133(1-2):160-74. PubMed ID: 12446019
[TBL] [Abstract][Full Text] [Related]
10. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Agostinho P; Cunha RA; Oliveira C
Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
[TBL] [Abstract][Full Text] [Related]
12. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.
Das S; Potter H
Neuron; 1995 Feb; 14(2):447-56. PubMed ID: 7857652
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
[TBL] [Abstract][Full Text] [Related]
15. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
16. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of microglial activation by propentofylline via cAMP signaling.
Si Q; Nakamura Y; Ogata T; Kataoka K; Schubert P
Brain Res; 1998 Nov; 812(1-2):97-104. PubMed ID: 9813261
[TBL] [Abstract][Full Text] [Related]
18. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
19. Microglia in Alzheimer's disease: the good, the bad and the ugly.
Tejera D; Heneka MT
Curr Alzheimer Res; 2016; 13(4):370-80. PubMed ID: 26567746
[TBL] [Abstract][Full Text] [Related]
20. Neuroglia: Functional Paralysis and Reactivity in Alzheimer's Disease and Other Neurodegenerative Pathologies.
Verkhratsky A; Zorec R; Rodriguez JJ; Parpura V
Adv Neurobiol; 2017; 15():427-449. PubMed ID: 28674992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
